The Drug Regulatory Authority of Pakistan (DRAP) has issued a nationwide alert warning the public against the use of certain medicines after identifying them as fake, substandard, and potentially dangerous. According to the regulator, specific batches of commonly used medicines—including Taskeen-e-Dard tablets, Pain-Nil tablets, and Duphalac syrup—have been declared counterfeit following laboratory testing.
DRAP said the affected products were being manufactured and distributed illegally without proper authorization, raising serious concerns about their safety, quality, and effectiveness. Health authorities warned that these medicines may fail to treat illnesses and could lead to harmful or even life-threatening effects due to unknown or incorrect ingredients.
The regulator has directed enforcement teams to immediately remove the identified batches from the market and take strict action against those involved in their production and sale. Pharmacies and distributors have been instructed to stop selling these medicines and verify their stock.
DRAP has also urged citizens to check the batch numbers of medicines they are using and avoid purchasing drugs from unlicensed sources. Patients have been advised to consult healthcare professionals if they suspect they have used any of the flagged products.
The alert is part of a broader crackdown on counterfeit medicines in Pakistan, as authorities continue efforts to protect public health and ensure the availability of safe and quality drugs.
